Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-21

FDA Approved: PROCHLORPERAZINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for prochlorperazine from Cosette Pharmaceuticals, Inc. for an already approved generic product (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • prochlorperazine (prochlorperazine)

Snippet

SUPPL AP for PROCHLORPERAZINE (PROCHLORPERAZINE)